J-P Machiels Selected Research

J-P Machiels Research Topics

Disease

10	Squamous Cell Carcinoma of Head and Neck 12/2023 - 07/2009
10	Neoplasms (Cancer) 12/2023 - 08/2012
3	Carcinoma (Carcinomatosis) 04/2014 - 10/2012
2	Residual Neoplasm 12/2023 - 09/2013
2	Disease Progression 01/2023 - 07/2015
2	Breast Neoplasms (Breast Cancer) 11/2013 - 06/2011
2	Transitional Cell Carcinoma 09/2013 - 10/2012
2	Heart Failure 03/2008 - 03/2008
2	Rectal Neoplasms (Rectal Cancer) 04/2007 - 12/2005
1	Nasopharyngeal Carcinoma 01/2023
1	Ovarian Epithelial Carcinoma 10/2022
1	Glioblastoma (Glioblastoma Multiforme) 10/2022
1	Hepatocellular Carcinoma (Hepatoma) 10/2022
1	Multiple Myeloma 10/2022
1	Diarrhea 01/2018
1	Renal Insufficiency (Renal Failure) 01/2018
1	Hypoxia (Hypoxemia) 11/2013
1	Urinary Bladder Neoplasms (Bladder Cancer) 09/2013
1	Adenocarcinoma 06/2006
1	Colorectal Neoplasms (Colorectal Cancer) 12/2005
1	Neoplasm Metastasis (Metastasis) 12/2005

Drug/Important Bio-Agent (IBA)

4	Cetuximab (Erbitux)FDA Link 12/2023 - 04/2007
3	PlatinumIBA 12/2023 - 10/2012
3	Biomarkers (Surrogate Marker)IBA 10/2022 - 10/2012
3	Capecitabine (Xeloda)FDA Link 04/2007 - 12/2005
2	B7-H1 AntigenIBA 01/2023 - 10/2022
2	Fluorouracil (Carac)FDA LinkGeneric 01/2023 - 05/2013
2	AfatinibIBA 01/2018 - 05/2013
2	ErbB Receptors (EGF Receptor)IBA 07/2015 - 08/2012
2	TOR Serine-Threonine KinasesIBA 11/2013 - 10/2012
2	Sirolimus (Rapamycin)FDA Link 11/2013 - 09/2013
2	MTOR InhibitorsIBA 11/2013 - 09/2013
2	Everolimus FDA Link 09/2013 - 10/2012
2	Sunitinib (Sutent)FDA Link 03/2008 - 03/2008
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 06/2006 - 12/2005
1	pembrolizumabIBA 12/2023
1	Circulating Tumor DNAIBA 12/2023
1	Docetaxel (Taxotere)FDA Link 12/2023
1	Methotrexate (Mexate)FDA LinkGeneric 12/2023
1	durvalumabIBA 01/2023
1	tremelimumabIBA 01/2023
1	CTLA-4 AntigenIBA 01/2023
1	atezolizumabIBA 10/2022
1	isatuximabIBA 10/2022
1	FluorineIBA 01/2018
1	Deoxyglucose (2 Deoxy D glucose)IBA 01/2018
1	Monoclonal AntibodiesIBA 07/2015
1	EpitopesIBA 07/2015
1	futuximabIBA 07/2015
1	Progesterone Receptors (Progesterone Receptor)IBA 04/2014
1	Chloroquine (Aralen)FDA LinkGeneric 11/2013
1	Paclitaxel (Taxol)FDA LinkGeneric 05/2013
1	Cisplatin (Platino)FDA LinkGeneric 05/2013
1	figitumumabIBA 08/2012
1	Insulin (Novolin)FDA Link 08/2012
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2012
1	Vinca AlkaloidsIBA 06/2011
1	TubulinIBA 06/2011
1	vinflunineIBA 06/2011
1	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2011
1	3-aminopyridine-2-carboxaldehyde thiosemicarbazone (triapine)IBA 07/2009
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 07/2009
1	Antineoplastic Agents (Antineoplastics)IBA 12/2005

Therapy/Procedure

6	Therapeutics 12/2023 - 10/2012
4	Drug Therapy (Chemotherapy) 12/2023 - 07/2009
3	Radiotherapy 04/2007 - 12/2005
1	Combined Modality Therapy 12/2023
1	Aftercare (After-Treatment) 10/2022
1	Immunotherapy 10/2022
1	Regimen B 05/2013
1	Neoadjuvant Therapy 06/2006